持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/11/06 | 6,090 | 6,300 | 6,090 | 6,260 | +130 | +2.1% | 28,300 |
| 2013/11/05 | 6,220 | 6,240 | 6,100 | 6,130 | -40 | -0.6% | 32,700 |
| 2013/11/01 | 6,260 | 6,260 | 6,160 | 6,170 | -60 | -1% | 20,500 |
| 2013/10/31 | 6,210 | 6,330 | 6,160 | 6,230 | -60 | -1% | 46,300 |
| 2013/10/30 | 6,210 | 6,320 | 6,210 | 6,290 | +50 | +0.8% | 51,100 |
| 2013/10/29 | 6,300 | 6,380 | 6,160 | 6,240 | -90 | -1.4% | 60,400 |
| 2013/10/28 | 6,320 | 6,340 | 6,260 | 6,330 | +80 | +1.3% | 15,400 |
| 2013/10/25 | 6,330 | 6,330 | 6,230 | 6,250 | -80 | -1.3% | 35,300 |
| 2013/10/24 | 6,210 | 6,360 | 6,210 | 6,330 | +60 | +1% | 26,000 |
| 2013/10/23 | 6,330 | 6,390 | 6,250 | 6,270 | -100 | -1.6% | 35,500 |
| 2013/10/22 | 6,380 | 6,390 | 6,310 | 6,370 | -10 | -0.2% | 23,900 |
| 2013/10/21 | 6,340 | 6,380 | 6,290 | 6,380 | +40 | +0.6% | 14,400 |
| 2013/10/18 | 6,330 | 6,370 | 6,270 | 6,340 | +10 | +0.2% | 22,900 |
| 2013/10/17 | 6,270 | 6,330 | 6,230 | 6,330 | +80 | +1.3% | 29,800 |
| 2013/10/16 | 6,220 | 6,260 | 6,170 | 6,250 | +40 | +0.6% | 25,000 |
| 2013/10/15 | 6,230 | 6,300 | 6,190 | 6,210 | +10 | +0.2% | 33,700 |
| 2013/10/11 | 6,320 | 6,320 | 6,170 | 6,200 | -40 | -0.6% | 32,900 |
| 2013/10/10 | 6,140 | 6,270 | 6,120 | 6,240 | +80 | +1.3% | 27,000 |
| 2013/10/09 | 6,030 | 6,180 | 6,030 | 6,160 | +100 | +1.7% | 34,800 |
| 2013/10/08 | 5,990 | 6,070 | 5,980 | 6,060 | +50 | +0.8% | 26,200 |
| 2013/10/07 | 5,990 | 6,140 | 5,990 | 6,010 | +30 | +0.5% | 33,500 |
| 2013/10/04 | 5,990 | 6,070 | 5,910 | 5,980 | -60 | -1% | 27,200 |
| 2013/10/03 | 5,970 | 6,080 | 5,960 | 6,040 | +100 | +1.7% | 29,400 |
| 2013/10/02 | 6,280 | 6,290 | 5,890 | 5,940 | -380 | -6% | 53,700 |
| 2013/10/01 | 6,420 | 6,440 | 6,310 | 6,320 | -110 | -1.7% | 30,400 |
| 2013/09/30 | 6,540 | 6,540 | 6,330 | 6,430 | -130 | -2% | 34,000 |
| 2013/09/27 | 6,550 | 6,610 | 6,470 | 6,560 | -20 | -0.3% | 29,300 |
| 2013/09/26 | 6,580 | 6,650 | 6,450 | 6,580 | +5,264 | +400% | 22,300 |
| 2013/09/25 | 1,315 | 1,336 | 1,308 | 1,316 | +1 | +0.1% | 70,000 |
| 2013/09/24 | 1,331 | 1,331 | 1,305 | 1,315 | -21 | -1.6% | 122,000 |
| 2013/09/20 | 1,336 | 1,346 | 1,331 | 1,336 | ±0 | ±0% | 90,000 |
| 2013/09/19 | 1,335 | 1,340 | 1,317 | 1,336 | +4 | +0.3% | 78,000 |
| 2013/09/18 | 1,315 | 1,335 | 1,314 | 1,332 | +26 | +2% | 65,000 |
| 2013/09/17 | 1,307 | 1,311 | 1,300 | 1,306 | +1 | +0.1% | 44,000 |
| 2013/09/13 | 1,311 | 1,331 | 1,296 | 1,305 | -26 | -2% | 178,000 |
| 2013/09/12 | 1,340 | 1,347 | 1,316 | 1,331 | -4 | -0.3% | 90,000 |
| 2013/09/11 | 1,322 | 1,337 | 1,322 | 1,335 | +13 | +1% | 62,000 |
| 2013/09/10 | 1,331 | 1,337 | 1,304 | 1,322 | -1 | -0.1% | 90,000 |
| 2013/09/09 | 1,320 | 1,328 | 1,294 | 1,323 | +32 | +2.5% | 88,000 |
| 2013/09/06 | 1,298 | 1,304 | 1,272 | 1,291 | +6 | +0.5% | 133,000 |
| 2013/09/05 | 1,292 | 1,292 | 1,276 | 1,285 | -13 | -1% | 63,000 |
| 2013/09/04 | 1,289 | 1,298 | 1,273 | 1,298 | +8 | +0.6% | 77,000 |
| 2013/09/03 | 1,275 | 1,294 | 1,273 | 1,290 | +21 | +1.7% | 83,000 |
| 2013/09/02 | 1,240 | 1,280 | 1,240 | 1,269 | +42 | +3.4% | 119,000 |
| 2013/08/30 | 1,259 | 1,277 | 1,208 | 1,227 | -17 | -1.4% | 206,000 |
| 2013/08/29 | 1,262 | 1,262 | 1,236 | 1,244 | -10 | -0.8% | 53,000 |
| 2013/08/28 | 1,245 | 1,255 | 1,222 | 1,254 | +2 | +0.2% | 56,000 |
| 2013/08/27 | 1,273 | 1,273 | 1,237 | 1,252 | -22 | -1.7% | 78,000 |
| 2013/08/26 | 1,268 | 1,294 | 1,253 | 1,274 | +6 | +0.5% | 65,000 |
| 2013/08/23 | 1,249 | 1,269 | 1,216 | 1,268 | +37 | +3% | 85,000 |
2701～
2750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
